HDAC9 and neoplasm: In SS, treating the conditional TAT-Cre SS18::SSX2 mouse tumor model that genetically lacks Pten with the HDAC inhibitor quisinostat induces cell death and decreases tumor burden, suggesting potential for a combinatorial approach (Laporte et al., 2017a; Laporte et al., 2017b).